Published in JAMA on April 10, 2013
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol (2014) 1.86
A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. JAMA Neurol (2015) 1.43
Effect of APOE and CD33 on Cognitive Decline. PLoS One (2015) 1.43
Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo. Springerplus (2014) 1.42
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score. PLoS Med (2017) 1.42
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology (2015) 1.21
Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways. Curr Genet Med Rep (2014) 1.18
Rare-variant extensions of the transmission disequilibrium test: application to autism exome sequence data. Am J Hum Genet (2013) 1.16
Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD). Front Cell Neurosci (2013) 1.11
Coding mutations in SORL1 and Alzheimer disease. Ann Neurol (2015) 1.09
Rare coding mutations identified by sequencing of Alzheimer disease genome-wide association studies loci. Ann Neurol (2015) 1.05
Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol (2014) 1.05
TREM2 is associated with increased risk for Alzheimer's disease in African Americans. Mol Neurodegener (2015) 1.05
Genome-wide association studies in Alzheimer's disease: a review. Curr Neurol Neurosci Rep (2013) 1.02
The genetics of Alzheimer's disease. Clin Interv Aging (2014) 1.01
Alzheimer's disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood) (2014) 1.00
CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility. Hum Mol Genet (2013) 0.97
Validation of a polygenic risk score for dementia in black and white individuals. Brain Behav (2014) 0.92
Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimers Dement (2014) 0.90
Genome-wide association studies, Alzheimer disease, and understudied populations. JAMA (2013) 0.88
ATP-binding Cassette Transporter A7 (ABCA7) Loss of Function Alters Alzheimer Amyloid Processing. J Biol Chem (2015) 0.88
Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment. Neurobiol Dis (2014) 0.85
Alzheimer's disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset. Future Sci OA (2016) 0.85
Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance. Front Aging Neurosci (2014) 0.85
ABCA7 frameshift deletion associated with Alzheimer disease in African Americans. Neurol Genet (2016) 0.84
Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations. Biol Psychiatry (2013) 0.84
Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease. Public Health Genomics (2014) 0.84
Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways. Neurobiol Aging (2013) 0.83
A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians. J Alzheimers Dis (2015) 0.82
Genetic Modifiers of Age at Onset in Carriers of the G206A Mutation in PSEN1 With Familial Alzheimer Disease Among Caribbean Hispanics. JAMA Neurol (2015) 0.82
Younger age of dementia diagnosis in a Hispanic population in southern California. Int J Geriatr Psychiatry (2014) 0.82
Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis. Med Sci Monit (2016) 0.82
Clinical genetics of Alzheimer's disease. Biomed Res Int (2014) 0.82
Identification and characterization of Aβ peptide interactors in Alzheimer's disease by structural approaches. Front Aging Neurosci (2014) 0.81
PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. Ann Neurol (2014) 0.81
F-box/LRR-repeat protein 7 is genetically associated with Alzheimer's disease. Ann Clin Transl Neurol (2015) 0.81
ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. J Neurosci (2016) 0.81
Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease. BMC Neurol (2015) 0.80
APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba. Int Psychogeriatr (2014) 0.80
Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European Americans. Carcinogenesis (2014) 0.80
Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities. Expert Rev Mol Diagn (2015) 0.79
The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease. Biomed Res Int (2014) 0.79
Role of Liver X Receptor in AD Pathophysiology. PLoS One (2015) 0.79
Characterization of genome-wide H3K27ac profiles reveals a distinct PM2.5-associated histone modification signature. Environ Health (2015) 0.79
Common genetic variants on 6q24 associated with exceptional episodic memory performance in the elderly. JAMA Neurol (2014) 0.78
Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol (2015) 0.78
Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome. BMC Res Notes (2014) 0.78
Association of APOE polymorphisms and stressful life events with dementia in a Pakistani population. Neurosci Lett (2014) 0.78
Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up. Alzheimer Dis Assoc Disord (2016) 0.77
Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement (2017) 0.76
Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans. Ethn Dis (2015) 0.76
Genes associated with Alzheimer's disease: an overview and current status. Clin Interv Aging (2016) 0.76
ABCA7 p.G215S as potential protective factor for Alzheimer's disease. Neurobiol Aging (2016) 0.76
ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep (2017) 0.75
Novel susceptibility loci for Alzheimer's disease. Future Neurol (2015) 0.75
A pilot study evaluating the contribution of SLC19A1 (RFC-1) 80G>a polymorphism to Alzheimer's disease in Italian Caucasians. Biomed Res Int (2014) 0.75
A Set-Based Mixed Effect Model for Gene-Environment Interaction and Its Application to Neuroimaging Phenotypes. Front Neurosci (2017) 0.75
Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians. J Alzheimers Dis (2015) 0.75
Neuropathologic differences by race from the National Alzheimer's Coordinating Center. Alzheimers Dement (2016) 0.75
Lack of association between cathepsin D C224T polymorphism and Alzheimer's disease risk: an update meta-analysis. BMC Neurol (2014) 0.75
Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease. PLoS One (2016) 0.75
Abca7 deletion does not affect adult neurogenesis in the mouse. Biosci Rep (2016) 0.75
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans. Alzheimers Dement (2016) 0.75
Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement (2015) 0.75
Genetic architecture of age-related cognitive decline in African Americans. Neurol Genet (2016) 0.75
Cognitive aging in black and white Americans: Cognition, cognitive decline, and incidence of Alzheimer disease dementia. Epidemiology (2017) 0.75
African American exome sequencing identifies potential risk variants at Alzheimer disease loci. Neurol Genet (2017) 0.75
APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans. PLoS One (2017) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res (1990) 14.82
The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques (1997) 11.94
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet (2012) 11.29
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
A versatile gene-based test for genome-wide association studies. Am J Hum Genet (2010) 8.44
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol (2010) 6.17
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol (2002) 5.69
The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology (2005) 5.64
Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol (2003) 4.37
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26
Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet (2009) 4.00
A 4-Mb high-density single nucleotide polymorphism-based map around human APOE. Genomics (1998) 3.91
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology (2006) 3.69
Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet (2009) 3.54
Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis (2003) 3.36
Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem (2000) 3.21
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20
Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA (2002) 3.16
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79
Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging (2000) 2.77
Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Worldwide prevalence and incidence of dementia. Drugs Aging (1999) 2.50
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59
Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol (2008) 1.44
Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol (2011) 1.42
A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol (2011) 1.33
Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging (2010) 1.22
ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem (2008) 1.20
Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch Neurol (2006) 1.19
The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res (2012) 1.18
Assessment of genotype imputation performance using 1000 Genomes in African American studies. PLoS One (2012) 1.10
Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system. J Atheroscler Thromb (2010) 1.02
White matter predictors of cognitive functioning in older adults. J Int Neuropsychol Soc (2012) 0.98
Comprehensive evaluation of imputation performance in African Americans. J Hum Genet (2012) 0.87
Finding the missing heritability of complex diseases. Nature (2009) 67.95
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79
Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet (2006) 13.16
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71
A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet (2010) 9.90
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med (2008) 9.61
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Demonstrating stratification in a European American population. Nat Genet (2005) 9.49
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42
Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature (2009) 8.09
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet (2006) 7.90
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science (2005) 7.03
Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry (2008) 6.73